semaglutide for mash Receives FDA Approval Treatment of Finally, it's officially here! ๐ฎ๐ณ
Description
Avoid injecting two medications in the exact same spot
2,3 Considerations may include efficacy, cost, potential adverse effects, weight consideration, comorbid medication conditions, risk of hypoglycemia, and patient preferences
:max_bytes(150000):strip_icc()/VWH-Wegovy-receives-FDA-approval-for-treating-MASH-51d3bd1a89894b5e80b8a1a093d30a63.jpg)
People microdosing GLP-1s do so for: Mitigating Side Effects: Standard doses of GLP-1 agonists can cause significant gastrointestinal side effects, including nausea, vomiting, diarrhea, and constipation (2)

Greater satiety: GLP-1s prolong feelings of fullness, making fasting periods more manageable and reducing the risk of overeating during eating windows
Clinical data demonstrates significant weight loss, metabolic improvements, and reduction in liver fat compared to placebo
